VCYT Latest Press Releases

-- November 12, 2026 --

Veracyte (VCYT) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:09 AM

-- November 10, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Veracyte (VCYT) Globe Newswire 10:11 AM

-- November 9, 2026 --

VCYT Investors Have Opportunity to Join Veracyte, Inc. Fraud Investigation with SBS Law Business Wire 4:22 PM

VCYT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Veracyte (VCYT) ACCESS Newswire 10:10 AM

-- November 6, 2026 --

VCYT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Veracyte PRNewswire 10:13 AM

-- November 5, 2026 --

Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT) PRNewswire 7:34 PM

VCYT Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Veracyte, Inc. Globe Newswire 4:58 PM

-- November 4, 2026 --

Veracyte Announces Third Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- November 2, 2026 --

Ten Afirma Abstracts to Highlight Thyroid Nodule Diagnosis and Cancer Research at ATA 2026 Globe Newswire 9:00 AM

-- October 29, 2026 --

Veracyte to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- October 23, 2026 --

Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer Globe Newswire 4:00 AM

-- October 19, 2026 --

Six Studies to Highlight Veracyte's Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026 Globe Newswire 8:00 AM

-- October 16, 2026 --

Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test Globe Newswire 9:15 AM

-- October 14, 2026 --

Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 Globe Newswire 4:05 PM

-- September 29, 2026 --

Phase III Trial Demonstrates Veracyte's Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation Globe Newswire 8:00 AM

-- September 25, 2026 --

Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026 Globe Newswire 5:12 PM

-- September 14, 2026 --

Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform Globe Newswire 4:05 PM

-- September 1, 2026 --

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 4:05 PM

-- July 30, 2026 --

Veracyte Announces Second Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- July 28, 2026 --

Veracyte to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- July 9, 2026 --

Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 Business Wire 4:05 PM

Market Data Delayed 15 Minutes